Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).

Elisa GiommoniEvaristo MaielloVanja VaccaroErmanno RondiniCaterina VivaldiGiampaolo TortoraLaura ToppoGuido GiordanoTiziana Pia LatianoCinzia LamperiniSerena Pillozzi Luca BoniLorenzo AntonuzzoFrancesco Di Costanzo

Published in: Current oncology (Toronto, Ont.) (2021)

Nab-FOLFIRI and Nab-FOLFOX might be hopeful first-line CT options for mPC patients, with promising activity and a good safety profile.

Keyphrases

metastatic colorectal cancer
advanced non small cell lung cancer
small cell lung cancer
computed tomography
epidermal growth factor receptor
contrast enhanced
magnetic resonance imaging
image quality
tyrosine kinase
pet ct